Chromium increases pancreatic metallothionein in the rat

Toxicology

Volumn 142, Issue 2, 1999, Pages 111-117

  Solis Heredia, M J ^a   Quintanilla Vega, B ^a   Sierra Santoyo, A ^a   Hernandez J M ^b   Brambila, E ^c   Cebrian M E ^a   Albores, A ^a  

^a Depto de Farmacol Y Toxicol   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Aspartate aminotransferase; Chromium; Kidney; Liver; Metallothionein; Pancreas; Amylase

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; BIOLOGICAL MARKER; CHROMIUM; GLUCOSE; METALLOTHIONEIN;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXOCRINE CELL; KIDNEY; LIVER TOXICITY; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

EID: 0344129018     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00130-4     Document Type: Article

References (34)

1. Albores A., Koropatnick J., Cherian M.G., Zelazowski A.J. Arsenic induces and enhances rat hepatic metallothionein production in vivo. Chem.-Biol. Interact. 85:1992;127-140.
2. Anderson R.A. Essentiality of chromium in humans. Sci. Total Environ. 86:1989;75-81.
3. Andrews G.K., Kage K., Palmiter-Thomas P., Sarras M.P. Metal ions induce expression of metallothionein in pancreatic exocrine and endocrine cells. Pancreas. 5:1990;458-554.
4. Bachur N.R., Gordon S.L., Gee M.V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 38:1978;1745-1755.
5. Bauman J.W., Liu J., Liu Y.P., Klaassen C.D. Increase in metallothionein production by chemicals that induce oxidative stress. Toxicol. Appl. Pharmacol. 110:1991;347-354.
6. Bremmer I., Davies N.T. The induction of metallothionein in rat liver by zinc injection and restriction of food intake. Biochem. J. 149:1975;733-738.
7. De Lisle R.C., Sarras M.P. Jr, Hidalgo J., Andrews G.K. Metallothionein is a component of exocrine pancreas secretion: implications for zinc homeostasis. Am. J. Physiol. 27:1996;C1103-C1110.
8. Dunn M.A., Blalock T.L., Cousins R.J. Metallothionein. Proc. Soc. Exp. Biol. Med. 185:1987;107-119.
9. Fleet J.C., Golemboski K.A., Kietert R.R., Andrews G.K., McCormick C.C. Induction of hepatic metallothionein by intraperitoneal metal injection: an associated inflammatory response. Am. J. Physiol. 258:1990;G926-G933.
10. Franchini I., Mutti A. Selected toxicologic aspects of chromium (VI) compounds. Sci. Total Environ. 71:1988;379-387.
11. Ghafghazi T., McDaniel M.L., Lacy P.E. Chromium-induced inhibition of insulin secretion from isolated islets of Langerhans. Diabetologia. 18:1980;229-232.
12. Ghoshal K., Wang Y., Sheridan J.F. Metallothionein induction in response to restrain stress. Transcriptional control, adaptation to stress and role of glucocorticoid. J. Biol. Chem. 43:1998;27904-27910.
13. Govindaraju K., Ramasami T., Ramaswamy D. Chromium(III)-insulin derivatives and their implication in glucose metabolism. J. Inorg. Biochem. 35:1989;137-147.
14. Huber K.L., Cousins R.J. Maternal zinc deprivation and interleukin-1 influence metallothionein gene expression and zinc metabolism of rats. J. Nutr. 118:1988;1570-1576.
15. Kelly E.J., Quaife C.J., Froelick G.J., Palmiter R.D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 126:1996;1782-1790.
16. Kim E., Na K.J. Effects of sodium dichromate on carbohydrate metabolism. Toxicol. Appl. Pharmacol. 110:1991;251-258.
17. Kim E., Na K.J. Nephrotoxicity of sodium dichromate depending on the route of administration. Arch. Toxicol. 65:1991;537-541.
18. Lehman-McKeeman L.D., Andrews G.K., Klaassen C.D. Induction of hepatic metallothioneins determined at isoprotein and messenger RNA levels in glucocorticoid-treated rats. Biochem. J. 244:1988;429-433.
19. McCarty M.F. Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. Med. Hypotheses. 46:1996;77-80.
20. McCormick C.C., Lin L.Y., Fleet J.C. Metalloforms of metallothionein induced by parenteral copper: the influence of route of administration. Adv. Exp. Med. Biol. 258:1989;123-130.
21. Minami T., Nakagawa H., Yoshimoto S., Asano I., Okazaki Y. Role of metallothionein in 4-aminopyrazolo(3,4-d)-pyrimidine-administered mouse pancreas. Biol. Pharm. Bull. 16:1993;1108-1110.
22. Minami, T., Matsubara, Tohno, Y., Tohno, S., Yamada, M., Kadota, E., Okazaki, Y., 1995. Different localization of metallothionein in mouse pancreas after induction by zinc or streptozotocin. Pharm. Sci. 1, 387-389.
23. Minami T., Shimizu M., Tanaka H., Okazaki Y., Cherian M.G. Metallothionein does not protect mouse endocrine cells from damage induced by alloxan injection. Toxicology. 132:1999;33-41.
24. Ohta H., Soewarno T., Yoshikawa H. Distribution of chromium and induction of metallothionein-like protein in rat livers injected with trivalent and hexavalent chromium. Arch. Gifu Med. 28:1980;205-210.
25. Ohta, H., Seki, Y., Imamiya, S., Yoshikawa, H., 1993. Metallothionein synthessis by trivalent or hexavalnt chromium in mice. In: Anke, M., Meissner, D. (Eds), Trace Elements in Man and Animals. pp. 178-179.
26. Onosaka S., Cherian M.G. The induced synthesis of metallothionein in various tissues of rats in response to metals. II. Influence of zinc statuss and specific effect on pancreatic metallothionein. Toxicology. 23:1982;111-120.
27. Onosaka S., Tanaka K., Cherian M.G. Effects of cadmium and zinc on tissue levels of metallothionein. Environ. Health Persp. 54:1984;67-72.
28. Scheuhammer A.M., Cherian M.G. Quantification of metallothioneins by a silver-saturation method. Toxicol. Appl. Pharmacol. 82:1986;417-425.
29. Standeven A.M., Wetterhahn K.E. Is there a role for reactive oxygen species in the mechanism of chromium (VI) carcinogenesis? Chem. Res. Toxicol. 4:1991;616-625.
30. Susuki C.A.M., Ohta H., Albores A., Koropatnick J., Cherian G. Induction of metallothionein synthesis by zinc in cadmium pretreated rats. Toxicology. 63:1990;273-284.
31. Waalkes M.P., Harvey M.J., Klaassen C.D. Relative in vitro affinity of hepatic metallothionein for metals. Toxicol. Lett. 20:1984;33-39.
32. Wormser U., Carp D. Increased levels of hepatic metallothionein in rat and mouse after injection of acetaminophen. Toxicology. 53:1988;329-332.
33. Yau E.T., Mennear J.H. Pancreatic metallothionein: protection against cadmium-induced inhibition of insulin secretory activity. Toxicol. Appl. Pharmacol. 39:1977;515-520.
34. Zimny S., Gogolin F., Abel J., Gleichmann H. Metallothionein in isolated pancreatic islets of mice: induction by zinc and streptozotocin, a naturally ocurring diabetogen. Arch. Toxicol. 67:1993;61-65.